There's no need to go over the stats for the COVID vaccine. We all know it. But SHINGRIX is now on the chopping block too? My god.

Shingles is a horrible virus and can sometimes have long term consequences. And guess what? Just as the mRNA technology they are so anxious to kill is showing vast promise for curing cancer, the shingles vaccine is looking more and more like a preventative for dementia:

A new study suggests that the vaccine for shingles may also be protective against dementia--findings that Harvard T.H. Chan School of Public Health's Alberto Ascherio calls "promising."

Ascherio, professor of epidemiology and nutrition, was among the experts quoted in a Dec. 2 Washington Post article about the study, which was led by researchers at Stanford University. (Ascherio was not involved.) Leveraging a natural experiment in Wales, researchers compared the cognitive outcomes of two groups of older adults--one that received the shingles vaccine, and another that didn't because they missed the eligibility cutoff. The study found that, among the vaccinated, those who remained cognitively healthy were less likely to develop mild cognitive impairment, and those who did develop dementia were nearly 30% less likely to die from it over the course of nine years.

The results "suggest that there is a slowing of this degenerative process," Ascherio told the Post. More research is needed to confirm the findings--but the study is a particularly strong one, Ascherio and others pointed out, because of its randomized controlled nature.

But sure, let's keep the information from the American people because some crank with a brain worm and his addled followers read something on YouTube.

For those eager for news about potential medical breakthroughs, there have been some encouraging headlines lately. Last month, for example, NBC News reported on an mRNA pancreatic cancer vaccine that’s shown promise in an early trial. More research is needed, but as the report added, “nearly all of the patients who responded to the personalized vaccine are still alive six years later.”

Less than a month later, the public received another round of good news directly related to mRNA research. NBC News also reported last week:

Messenger RNA technology, or mRNA, is widely seen as a promising way to improve the effectiveness of flu shots, partly because it can be updated more quickly to match circulating strains.

New results published Wednesday in the New England Journal of Medicine found Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a Phase 3 clinical trial.

The report quoted Dorit Reiss, a vaccine policy expert at the University of California Law San Francisco, who said, “These are strong results, and would likely make it hard for the FDA to refuse in a way that withstands arbitrary and capricious review.”....

Dr. Jerome Adams, who served as the surgeon general during Trump’s first term, added via social media, “I’ve tried to be objective & non-alarmist in response to current HHS actions — but quite frankly this move is going to cost lives.”

The president tried to defend the shift, but he failed. Kennedy tried, too, and he fared about as well. When Dr. Jay Bhattacharya, Trump’s handpicked director of the National Institutes of Health and acting head of the Centers for Disease Control and Prevention, wrote an op-ed for The Washington Post making his best case, it collapsed rather quickly.

The more the public is confronted with evidence of what’s possible with mRNA vaccines, the more we’re reminded of how drastic a mistake the administration made and why it remains incumbent on Team Trump to reverse course.